Persistent Human Papillomavirus Infection as a Predictor of Cervical Intraepithelial Neoplasia

Schlecht, Nicolas F.

doi:10.1001/jama.286.24.3106

Cited by 590Cervical Cancer and HPV ResearchReproductive tract infections researchWomen's cancer prevention and management

Persistent Human Papillomavirus Infection as a Predictor of Cervical Intraepithelial Neoplasia

Schlecht, Nicolas F.·2001·JAMA

DOI 10.1001/jama.286.24.3106

Open this paper in CoChat — free account

Abstract

Context Human papillomavirus (HPV) infection is believed to be the central cause of cervical cancer, although most of the epidemiological evidence has come from retrospective, case-control studies, which do not provide information on the dynamics of cumulative or persistent exposure to HPV infection. Objective To assess the risks of cervical neoplasia related to prior persistent HPV infections. Design and setting Longitudinal study of the natural history of HPV infection and cervical neoplasia in women residing in the city of São Paulo, Brazil, which was conducted between November 1993 and March 1997 and involved repeated measurements of HPV and lesions with follow-up until June 2000. Participants A total of 1611 women with no cytological lesions at enrollment and HPV test results available from the first 2 visits. Main outcome measure Cervical specimens taken for Papanicolaou cytology and HPV testing every 4 months in the first year and twice yearly thereafter. Incident cervical cancer precursor lesions ascertained by expert review of all cytology smears. Results The incidence rate of squamous intraepithelial lesions (SILs) was 0.73 per 1000 women-months (95% confidence interval [CI], 0.5-0.9) among women free of HPV at the 2 initial visits and 8.68 (95% CI, 2.3-15.1) among women with HPV type 16 or 18 infections persisting over both visits. Relative to those negative for HPV oncogenic types at both initial visits, the relative risk (RR) of incident SIL was 10.19 (95% CI, 5.…

Integrity signals

Registry

Crossref · 10.1001/jama.286.24.3106

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Full HPV genotyping is useful clinically to identify patients with persisting, type-specific high-risk HPV infections, which confer a higher risk of cancer progression than incident infections by the same high-risk type.
“Full HPV genotyping is also useful clinically to identify patients with persisting, type-specific high-risk HPV infections which are known to confer a higher risk of cancer progression than incident infections by the same high-risk type (11).”
From Comparison of Seegene Anyplex II HPV28 with the PGMY-CHUV Assay for Human Papillomavirus Genotyping (2014) · cites this paper as [11]

IARC Monographs on the Evaluation of Carcinogenic Risks to Humans
Zuckerman, A. J. (1995) · Journal of Clinical Pathology · doi:10.1136/jcp.48.7.691-a · Cited by 8,761 · see citing works
NATURAL HISTORY OF CERVICOVAGINAL PAPILLOMAVIRUS INFECTION IN YOUNG WOMEN
Loria, G. R., Ierman, R. O. B., Eardsley, L. E. B., & Hang, H. J. C. (1998) · Cited by 1,887 · see citing works
Genital Human Papillomavirus Infection in Female University Students as Determined by a PCR-Based Method
Bauer, H. M. (1991) · JAMA · doi:10.1001/jama.1991.03460040048027 · Cited by 961 · see citing works
A Cohort Study of the Risk of Cervical Intraepithelial Neoplasia Grade 2 or 3 in Relation to Papillomavirus Infection
Koutsky, L. A., Holmes, K. K., Critchlow, C. W., Stevens, C. E., Paavonen, J. A., Beckmann, A. M., DeRouen, T. A., Galloway, D. A., Vernon, D., & Kiviat, N. B. (1992) · New England Journal of Medicine · doi:10.1056/nejm199210293271804 · Cited by 940 · see citing works
Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study
Woodman, C. B. J., Collins, S. I., Winter, H., Bailey, A. C., Ellis, J. R., Prior, P., Yates, M., Rollason, T. P., & Young, L. S. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04956-4 · Cited by 819 · see citing works
Persistent Genital Human Papillomavirus Infection as a Risk Factor for Persistent Cervical Dysplasia
Ho, G. Y. F., Burk, R. D., Klein, S., Kadish, A. S., Chang, C., PALAN, P., Basu, J., Tachezy, R., Lewis, R., & Romney, S. L. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.18.1365 · Cited by 804 · see citing works
Persistence of Type-Specific Human Papillomavirus Infection among Cytologically Normal Women
Hildesheim, A., SCHIFFMAN, M. H., Gravitt, P. E., Glass, A. G., Greer, C. E., Zhang, T., Scott, D. R., Rush, B. B., Lawler, P., Sherman, M. E., et al. (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/169.2.235 · Cited by 682 · see citing works
The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women
Moscicki, A., Shiboski, S. C., Broering, J. M., Powell, K., Clayton, L., Jay, N., Darragh, T. M., Brescia, R. J., Kanowitz, S., Miller, S., et al. (1998) · The Journal of Pediatrics · doi:10.1016/s0022-3476(98)70445-7 · Cited by 562 · see citing works
Risks for Incident Human Papillomavirus Infection and Low-Grade Squamous Intraepithelial Lesion Development in Young Females
Moscicki, A. (2001) · JAMA · doi:10.1001/jama.285.23.2995 · Cited by 560 · see citing works
Epidemiologic Evidence and Human Papillomavirus Infection as a Necessary Cause of Cervical Cancer
Franco, E. L., Rohan, T. E., & VILLA, L. L. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.6.506 · Cited by 538 · see citing works
Type-Specific Persistence of Human Papillomavirus DNA before the Development of Invasive Cervical Cancer
Wallin, K.-L., Wiklund, F. E., Ångström, T., Bergman, F., Stendahl, U., Wadell, G., Hallmans, G., & Dillner, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199911253412201 · Cited by 493 · see citing works
Incidence of Cervical Squamous Intraepithelial Lesions in HIV-Infected Women
Ellerbrock, T. V. (2000) · JAMA · doi:10.1001/jama.283.8.1031 · Cited by 481 · see citing works
Identification and Assessment Of Known And Novel Human Papillomaviruses by Polymerase Chain Reaction Amplification, Restriction Fragment Length Polymorphisms, Nucleotide Sequence, and Phylogenetic Algorithms
Bernard, H., Chan, S. Y., Manos, M. M., Ong, C. K., Villa, L. L., Delius, H., Peyton, C. L., Bauer, H. M., & Wheeler, C. M. (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/170.5.1077 · Cited by 479 · see citing works
Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study
Ylitalo, N., Sørensen, P. S., Josefsson, A., Magnusson, P. K. E., Andersen, P. K., Pontén, J., Adami, H., Gyllensten, U. B., & Melbye, M. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02402-8 · Cited by 351 · see citing works
Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia
Villa, L. L., Sichero, L. C., Rahal, P., Caballero, O. L., Ferenczy, A. S., Rohan, T. E., & Franco, E. L. (2000) · Journal of General Virology · doi:10.1099/0022-1317-81-12-2959 · Cited by 298 · see citing works
Detection of Human Papillomavirus DNA in Cytologically Normal Women and Subsequent Cervical Squamous Intraepithelial Lesions
Liaw, K.-L., Glass, A. G., Manos, M. M., Greer, C. E., Scott, D. R., Sherman, M. E., Burk, R. D., Kurman, R. J., Wacholder, S., Rush, B. B., et al. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.11.954 · Cited by 242 · see citing works
Determinants of Genital Human Papillomavirus Infection in Low-Risk Women in Portland, Oregon
Bauer, H. M., Hildesheim, A., Schiffman, M. H., Glass, A. G., Rush, B. B., Scott, D. R., Cadell, D. M., Kurman, R. J., & Manos, M. M. (1993) · Sexually Transmitted Diseases · doi:10.1097/00007435-199309000-00007 · Cited by 233 · see citing works
Human papillomavirus genotype as a predictor of persistence and development of high‐grade lesions in women with minor cervical abnormalities
Londesborough, P., Ho, L., Terry, G., Cuzick, J. M., Wheeler, C. M., & Singer, A. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19961021)69:5 · Cited by 224 · see citing works
Design and methods of the Ludwig-McGill longitudinal study of the natural history of human papillomavirus infection and cervical neoplasia in Brazil
Franco, E. L., Villa, L. L., Rohan, T. E., Ferenczy, A. S., Petzl‐Erler, M. L., & Matlashewski, G. (1999) · Revista Panamericana de Salud Pública · doi:10.1590/s1020-49891999000900001 · Cited by 102 · see citing works
The 1988 bethesda system for reporting cervical/vaginal cytologic diagnoses: Developed and approved at the National Cancer Institute workshop in Bethesda, Maryland, December 12–13, 1988
Solomon, D. (1990) · Human Pathology · doi:10.1016/0046-8177(90)90029-5 · Cited by 77 · see citing works
Prospective follow-up of cervical HPV infections: Life table analysis of histopathological, cytological and colposcopic data
Kataja, V. V., Syrj�nen, K. J., M�ntyj�rvi, R., V�yrynen, M., Syrj�nen, S. M., Saarikoski, S., Parkkinen, S., Yliskoski, M. H., Salonen, J. T., & Castrén, O. (1989) · European Journal of Epidemiology · doi:10.1007/bf00145037 · Cited by 70 · see citing works
Molecular Variant Analysis as an Epidemiological Tool to Study Persistence of Cervical Human Papillomavirus Infection
Franco, E. L., Villa, L. L., Rahal, P., & RUIZ, A. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.20.1558 · Cited by 29 · see citing works

Flagged first, then by citations

Sorted by citations

Papillomaviruses and cancer: from basic studies to clinical application
Hausen, H. Z. (2002) · Nature reviews. Cancer · doi:10.1038/nrc798 · Cited by 4,031 · see citing works
The causal relation between human papillomavirus and cervical cancer
Bosch, F. X., Lorincz, A. T., Munoz, N., Meijer, C. J. L. M., & Shah, K. V. (2002) · Journal of Clinical Pathology · doi:10.1136/jcp.55.4.244 · Cited by 3,540 · see citing works
ACOG PRACTICE BULLETIN
Gynecologists (2009) · Cited by 1,035 · see citing works
The epidemiology of human papillomavirus infections
Baseman, J. G., & Koutsky, L. A. (2005) · Journal of Clinical Virology · doi:10.1016/j.jcv.2004.12.008 · Cited by 955 · see citing works
2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests
Wright, T. C., Massad, L. S., Dunton, C. J., Spitzer, M., Wilkinson, E. J., & Solomon, D. (2007) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.07.047 · Cited by 829 · see citing works
Human Papillomavirus Testing in the Prevention of Cervical Cancer
SCHIFFMAN, M. H., Wentzensen, N., Wacholder, S., Kinney, W., Gage, J. C., & Castle, P. E. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq562 · Cited by 759 · see citing works
The epidemiology of genital human papillomavirus infection
Trottier, H., & Franco, E. L. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.09.054 · Cited by 689 · see citing works
Natural history and epidemiology of HPV infection and cervical cancer
Castellsagué, X. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.07.045 · Cited by 591 · see citing works
Immune responses to human papillomavirus
Stanley, M. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.09.002 · Cited by 589 · see citing works
The carcinogenicity of human papillomavirus types reflects viral evolution
SCHIFFMAN, M. H., Herrero, R., DeSalle, R., Hildesheim, A., Wacholder, S., Rodríguez, A. C., Bratti, M. C., Sherman, M. E., Morales, J., Guillén, D., et al. (2005) · Virology · doi:10.1016/j.virol.2005.04.002 · Cited by 555 · see citing works
Projected Clinical Benefits and Cost-effectiveness of a Human Papillomavirus 16/18 Vaccine
Goldie, S. J., Kohli, M. A., Grima, D. T., Weinstein, M. C., Wright, T. C., Bosch, F. X., & Franco, E. L. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh104 · Cited by 538 · see citing works
Interim Guidance for the Use of Human Papillomavirus DNA Testing as an Adjunct to Cervical Cytology for Screening
Wright, T. C., Schiffman, M., Solomon, D., Cox, J. T., García, F., Goldie, S. J., Hatch, K. D., Noller, K. L., Roach, N., Runowicz, C. D., et al. (2004) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000109426.82624.f8 · Cited by 499 · see citing works
Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: A longitudinal French cohort study
Dalstein, V., Riethmuller, D., Prétet, J., Le Bail Carval, K., Sautière, J., Carbillet, J., Kantelip, B., Schaal, J., & Mougin, C. (2003) · International Journal of Cancer · doi:10.1002/ijc.11222 · Cited by 435 · see citing works
Persistent Human Papillomavirus Infection and Cervical Neoplasia: A Systematic Review and Meta-Analysis
Koshiol, J. E., Lindsay, L., Pimenta, J. M., Poole, C., Jenkins, D., & Smith, J. S. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn036 · Cited by 437 · see citing works
Interplay between the temporal dynamics of the vaginal microbiota and human papillomavirus detection
Brotman, R. M., Shardell, M. D., Gajer, P., Tracy, J. K., Zenilman, J. M., Ravel, J., & Gravitt, P. E. (2014) · Journal of Infectious Diseases · doi:10.1093/infdis/jiu330 · Cited by 411 · see citing works
A Prospective Study of Age Trends in Cervical Human Papillomavirus Acquisition and Persistence in Guanacaste, Costa Rica
Castle, P. E., SCHIFFMAN, M. H., Herrero, R., Hildesheim, A., Rodríguez, A. C., Bratti, M. C., Sherman, M. E., Wacholder, S., Tarone, R. E., & Burk, R. D. (2005) · The Journal of Infectious Diseases · doi:10.1086/428779 · Cited by 404 · see citing works
Human papillomavirus types among women infected with HIV: a meta-analysis
Clifford, G. M., Gonçalves, M. A. G., & Franceschi, S. (2006) · AIDS · doi:10.1097/01.aids.0000253361.63578.14 · Cited by 395 · see citing works
Age-Specific Prevalence of Infection with Human Papillomavirus in Females: A Global Review
Smith, J. S., Melendy, A., Rana, R. K., & Pimenta, J. M. (2008) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2008.07.009 · Cited by 377 · see citing works
Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening
Bray, F., Loos, A. H., McCarron, P., Weiderpass, E., Arbyn, M., Møller, H., Hakama, M., & Parkin, D. M. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0569 · Cited by 370 · see citing works
2006 Consensus Guidelines for the Management of Women With Abnormal Cervical Screening Tests
Wright, T. C., Massad, L. S., Dunton, C. J., Spitzer, M., Wilkinson, E. J., & Solomon, D. (2007) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0b013e3181585870 · Cited by 353 · see citing works
Human Papillomavirus Infections with Multiple Types and Risk of Cervical Neoplasia
Trottier, H., Mahmud, S., Costa, M. C., Sobrinho, J. P., Duarte-Franco, E., Rohan, T. E., Ferenczy, A., Villa, L. L., & Franco, E. L. (2006) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0129 · Cited by 352 · see citing works
Human Papillomavirus Infection and Time to Progression and Regression of Cervical Intraepithelial Neoplasia
Schlecht, N. F. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg037 · Cited by 335 · see citing works
Self-citation
Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months
Ogilvie, G. S., van Niekerk, D., Krajden, M., Smith, L., Cook, D. A., Gondara, L., Ceballos, K. M., Quinlan, D., Lee, M. H., Martin, R. E., et al. (2018) · JAMA · doi:10.1001/jama.2018.7464 · Cited by 283 · see citing works
Real-Time PCR Technology for Cancer Diagnostics
Bernard, P. S., & Wittwer, C. T. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.8.1178 · Cited by 273 · see citing works
Cost-effectiveness of Alternative Triage Strategies for Atypical Squamous Cells of Undetermined Significance
Kim, J. J. (2002) · JAMA · doi:10.1001/jama.287.18.2382 · Cited by 266 · see citing works
Epidemiology and burden of HPV infection and related diseases: Implications for prevention strategies
Tota, J. E., Chévarie‐Davis, M., Richardson, L., deVries, M., & Franco, E. L. (2011) · Preventive Medicine · doi:10.1016/j.ypmed.2011.08.017 · Cited by 261 · see citing works
Human papillomavirus infection: biology, epidemiology, and prevention
Scheurer, M. E., Tortolero‐Luna, G., & Adler‐Storthz, K. (2005) · International Journal of Gynecological Cancer · doi:10.1111/j.1525-1438.2005.00246.x · Cited by 257 · see citing works
The Epidemiology of Cervical Cancer
Franco, E. L., Schlecht, N. F., & Saslow, D. (2003) · The Cancer Journal · doi:10.1097/00130404-200309000-00004 · Cited by 252 · see citing works
Self-citation
Human papillomavirus in cervical and head-and-neck cancer
Psyrri, A. K., & DiMaio, D. (2007) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0984 · Cited by 242 · see citing works
Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort
Peto, J., Gilham, C., Deacon, J., Taylor, C., Evans, C., Wh, B., Haywood, M. E. K., Elanko, N., Coleman, D. V., Yule, R., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602049 · Cited by 236 · see citing works
Patterns of persistent genital human papillomavirus infection among women worldwide: A literature review and meta-analysis
Rositch, A. F., Koshiol, J. E., Hudgens, M. G., Razzaghi, H., Backes, D. M., Pimenta, J. M., Franco, E. L., Poole, C., & Smith, J. S. (2012) · International Journal of Cancer · doi:10.1002/ijc.27828 · Cited by 235 · see citing works
Incidence, clearance and predictors of human papillomavirus infection in women.
Sellors, J. W., Karwalajtys, T. L., Kaczorowski, J. A., Mahony, J. B., Lytwyn, A., Chong, S., Sparrow, J., & Lorincz, A. T. (2003) · PubMed Central · Cited by 230 · see citing works
Is vaccination with quadrivalent HPV vaccine after loop electrosurgical excision procedure effective in preventing recurrence in patients with high-grade cervical intraepithelial neoplasia (CIN2–3)?
Kang, W. D., Choi, H. S., & Kim, S. M. (2013) · Gynecologic Oncology · doi:10.1016/j.ygyno.2013.04.050 · Cited by 221 · see citing works
Persistence of Human Papillomavirus Infection in HIV‐Infected and ‐Uninfected Adolescent Girls: Risk Factors and Differences, by Phylogenetic Type
Moscicki, A., Ellenberg, J. H., Farhat, S., & Xu, J. (2004) · The Journal of Infectious Diseases · doi:10.1086/421467 · Cited by 220 · see citing works
A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV‐16/18 vaccine
Goldie, S. J., Grima, D., Kohli, M., Wright, T. C., Weinstein, M., & Franco, E. (2003) · International Journal of Cancer · doi:10.1002/ijc.11334 · Cited by 209 · see citing works
Cost-Effectiveness of Human Papillomavirus DNA Testing for Cervical Cancer Screening in Women Aged 30 Years or More
Goldie, S. J., Kim, J. J., & Wright, T. C. (2004) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000120143.50098.c7 · Cited by 207 · see citing works
The Absolute Risk of Cervical Abnormalities in High-risk Human Papillomavirus–Positive, Cytologically Normal Women Over a 10-Year Period
Kjær, S. K., Høgdall, E. V. S., Frederiksen, K., Munk, C., van den Brule, A. J. C., Svare, E. I., Meijer, C. J. L. M., Lörincz, A. T., & Iftner, T. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1057 · Cited by 206 · see citing works
Persistence of Type-Specific Human Papillomavirus Infection and Increased Long-term Risk of Cervical Cancer
Chen, H.-C., SCHIFFMAN, M. H., Lin, C., Pan, M., You, S., Chuang, L.-C., Hsieh, C. ‐., Liaw, K.-L., Hsing, A. W., Chen, C., et al. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr283 · Cited by 200 · see citing works
The role of inflammation in HPV carcinogenesis
Boccardo, E., Lepique, A. P., & Villa, L. L. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq176 · Cited by 195 · see citing works
Type‐Specific Duration of Human Papillomavirus Infection: Implications for Human Papillomavirus Screening and Vaccination
Trottier, H., Mahmud, S. M., Prado, J. C. M., Sobrinho, J. S., Costa, M. C., Rohan, T. E., Villa, L. L., & Franco, E. L. (2008) · The Journal of Infectious Diseases · doi:10.1086/587698 · Cited by 188 · see citing works
Risk for High-Grade Cervical Intraepithelial Neoplasia Associated with Variants of Human Papillomavirus Types 16 and 18
Xi, L. F., Koutsky, L. A., Hildesheim, A., Galloway, D. A., Wheeler, C. M., Winer, R. L., Ho, J., & Kiviat, N. B. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0670 · Cited by 169 · see citing works
Viral load as a predictor of the risk of cervical intraepithelial neoplasia
Schlecht, N. F., Trevisan, A., Duarte‐Franco, E., Rohan, T. E., Ferenczy, A. S., Villa, L. L., & Franco, E. L. (2002) · International Journal of Cancer · doi:10.1002/ijc.10846 · Cited by 163 · see citing works
Self-citation
The vaginal metabolome and microbiota of cervical HPV‐positive and HPV‐negative women: a cross‐sectional analysis
Borgogna, J.-L. C., Shardell, M. D., Santori, E. K., Nelson, T., Rath, J. M., Glover, E., Ravel, J., Gravitt, P. E., Yeoman, C. J., & Brotman, R. M. (2019) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.15981 · Cited by 169 · see citing works
HPV16 Tumor Associated Macrophages Suppress Antitumor T Cell Responses
Lepique, A. P., Perez, K. R., Cuccovia, I. M., & Villa, L. L. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0489 · Cited by 159 · see citing works
Epidemiology of Mucosal Human Papillomavirus Infection and Associated Diseases
Trottier, H., & Burchell, A. N. (2009) · Public Health Genomics · doi:10.1159/000214920 · Cited by 156 · see citing works
Clearance of oncogenic human papillomavirus (HPV) infection: effect of smoking (United States)
Giuliano, A. R., Sedjo, R. L., Roe, D. J., Harris, R. B., Baldwin, S. B., Papenfuss, M. R., Abrahamsen, M. E., & Inserra, P. F. (2002) · Cancer Causes & Control · doi:10.1023/a:1020668232219 · Cited by 155 · see citing works
Modified General Primer PCR System for Sensitive Detection of Multiple Types of Oncogenic Human Papillomavirus
Söderlund‐Strand, A., Carlson, J. A., & Dillner, J. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.02007-08 · Cited by 150 · see citing works
Chapter 13: Primary Screening of Cervical Cancer With Human Papillomavirus Tests
Franco, E. L. (2003) · JNCI Monographs · doi:10.1093/oxfordjournals.jncimonographs.a003488 · Cited by 146 · see citing works
Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial
Elfstrom, K. M., Smelov, V., Johansson, A. L. V., Eklund, C., Naucler, P., Arnheim-Dahlstrom, L., & Dillner, J. (2014) · BMJ · doi:10.1136/bmj.g130 · Cited by 142 · see citing works
Human Papillomavirus Genotypes and the Cumulative 2‐Year Risk of Cervical Precancer
Wheeler, C. M., Hunt, W. C., SCHIFFMAN, M. H., Castle, P. E., & Atypical Squamous Cells of Undetermined Significance/Low‐Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group (2006) · The Journal of Infectious Diseases · doi:10.1086/507909 · Cited by 142 · see citing works
Betapapillomaviruses frequently persist in the skin of healthy individuals
de Koning, M. N. C., Struijk, L., Bavinck, J. N. B., Kleter, B., ter Schegget, J., Quint, W. G. V., & Feltkamp, M. C. W. (2007) · Journal of General Virology · doi:10.1099/vir.0.82732-0 · Cited by 129 · see citing works
Recurrent human papillomavirus infection detected with the hybrid capture II assay selects women with normal cervical smears at risk for developing high grade cervical lesions: A longitudinal study of 3,091 women
Bory, J., Cucherousset, J., Lorenzato, M., Gabriel, R., Quéreux, C., Birembaut, P. L., & Clavel, C. (2002) · International Journal of Cancer · doi:10.1002/ijc.10735 · Cited by 125 · see citing works
Commercially available assays for multiplex detection of alpha human papillomaviruses
Poljak, M., & Kocjan, B. J. (2010) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.10.104 · Cited by 122 · see citing works
Highly Active Antiretroviral Therapy and Cervical Squamous Intraepithelial Lesions in Human Immunodeficiency Virus-Positive Women
Ahdieh, L., Li, R. Q., Levine, A. M., Massad, L. S., Strickler, H. D., MINKOFF, H. L., Moxley, M. D., Palefsky, J. M., Sacks, H. S., Burk, R. D., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh192 · Cited by 121 · see citing works
Modeling Human Papillomavirus Vaccine Effectiveness: Quantifying the Impact of Parameter Uncertainty
van de Velde, N., Brisson, M., & Boily, M. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwk059 · Cited by 118 · see citing works
Association of Condom Use, Sexual Behaviors, and Sexually Transmitted Infections With the Duration of Genital Human Papillomavirus Infection Among Adolescent Women
Shew, M. L., Fortenberry, J. D., Tu, W., Juliar, B. E., Batteiger, B. E., Qadadri, B., & Brown, D. R. (2006) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.160.2.151 · Cited by 118 · see citing works
Immune response to human papillomavirus after prophylactic vaccination with AS04-adjuvanted HPV-16/18 vaccine: Improving upon nature
Schwarz, T. F., & Léo, O. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.05.036 · Cited by 117 · see citing works
Incident High-Grade Squamous Intraepithelial Lesions in Senegalese Women With and Without Human Immunodeficiency Virus Type 1 (HIV-1) and HIV-2
Hawes, S. E., Critchlow, C. W., Sow, P. S., Touré, P. S., N'doye, I., Diop, A., Kuypers, J. M., Kasse, A. A., & Kiviat, N. B. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj010 · Cited by 112 · see citing works
Dietary Intake and Risk of Persistent Human Papillomavirus (HPV) Infection: The Ludwig‐McGill HPV Natural History Study
Giuliano, A. R., Siegel, E. M., Roe, D. J., Ferreira, S., Baggio, M. L., Galan, L., Duarte‐Franco, E., Villa, L. L., Rohan, T. E., Marshall, J. R., et al. (2003) · The Journal of Infectious Diseases · doi:10.1086/379197 · Cited by 111 · see citing works
Advances in Prevention of Cervical Cancer and Other Human Papillomavirus-Related Diseases
Frazer, I. H., Cox, J. T., Mayeaux, E. J., Franco, E. L., Moscicki, A., Palefsky, J. M., Ferris, D. G., Ferenczy, A. S., & Villa, L. L. (2006) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000196485.86376.46 · Cited by 111 · see citing works
Human papillomavirus vaccines
Stanley, M. (2006) · Reviews in Medical Virology · doi:10.1002/rmv.498 · Cited by 107 · see citing works
The predicted effect of changes in cervical screening practice in the UK: results from a modelling study
Canfell, K., Barnabas, R. V., Patnick, J., & Beral, V. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602002 · Cited by 102 · see citing works
Interactions of IL-12A and IL-12B Polymorphisms on the Risk of Cervical Cancer in Chinese Women
Chen, X., Han, S., Wang, S., Zhou, X., Zhang, M., Dong, J., Shi, X., 钱年凤, Wang, X., Wei, Q., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1829 · Cited by 100 · see citing works
Epidemiology and natural history of genital human papillomavirus infection.
Weaver, B. A. (2006) · PubMed · Cited by 95 · see citing works
Interaction among Folate, Riboflavin, Genotype, and Cancer, with Reference to Colorectal and Cervical Cancer
Powers, H. J. (2005) · Journal of Nutrition · doi:10.1093/jn/135.12.2960s · Cited by 100 · see citing works
Can human papillomavirus DNA testing of self-collected vaginal samples compare with physician-collected cervical samples and cytology for cervical cancer screening in developing countries?
Bhatla, N., Dar, L., Patro, A. R., Kumar, P., Kriplani, A., Gulati, A., Iyer, V. K., Mathur, S. R., Sreenivas, V., Shah, K. V., et al. (2009) · Cancer Epidemiology · doi:10.1016/j.canep.2009.10.013 · Cited by 99 · see citing works
G-308A TNF-α polymorphism is associated with an increased risk of invasive cervical cancer
Duarte, I., Santos, A. M., de Sousa, H. M. L., Catarino, R., Pinto, D., Matos, A., Pereira, D., Moutinho, J., Canedo, P., Machado, J. C., et al. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.06.137 · Cited by 98 · see citing works
Comparison of Linear Array and Line Blot Assay for Detection of Human Papillomavirus and Diagnosis of Cervical Precancer and Cancer in the Atypical Squamous Cell of Undetermined Significance and Low-Grade Squamous Intraepithelial Lesion Triage Study
Castle, P. E., Gravitt, P. E., Solomon, D., Wheeler, C. M., & SCHIFFMAN, M. H. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01667-07 · Cited by 98 · see citing works
Folate Is Associated with the Natural History of High-Risk Human Papillomaviruses
Piyathilake, C. J., Henao, O. L., Macaluso, M., Cornwell, P. E., Meleth, S., Heimburger, D. C., & Partridge, E. E. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2402 · Cited by 97 · see citing works
Human Leukocyte Antigen Class II and Cervical Cancer Risk: A Population‐Based Study
Madeleine, M. M., Brumback, B., Cushing‐Haugen, K. L., Schwartz, S. M., Daling, J. R., Smith, A. G., Nelson, J. L., Porter, P. L., Shera, K. A., McDougall, J. K., et al. (2002) · The Journal of Infectious Diseases · doi:10.1086/345285 · Cited by 96 · see citing works
Evaluation of Toll-like receptors 3 (c.1377C/T) and 9 (G2848A) gene polymorphisms in cervical cancer susceptibility
Pandey, S., Mittal, B., Srivastava, M., Singh, S., Srivastava, K., Lal, P., & Mittal, R. D. (2010) · Molecular Biology Reports · doi:10.1007/s11033-010-0607-z · Cited by 95 · see citing works
Vitamin A, carotenoids, and risk of persistent oncogenic human papillomavirus infection.
Sedjo, R. L., Roe, D. J., Abrahamsen, M. E., Harris, R. B., Craft, N. E., Baldwin, S. B., & Giuliano, A. R. (2002) · PubMed · Cited by 94 · see citing works
Predictors of cervical coinfection with multiple human papillomavirus types.
Rousseau, M., Abrahamowicz, M., Villa, L. L., Costa, M. C., Rohan, T. E., & Franco, E. L. (2003) · PubMed · Cited by 92 · see citing works
Time to clearance of human papillomavirus infection by type and human immunodeficiency virus serostatus
Koshiol, J. E., Schroeder, J. C., Jamieson, D. J., Marshall, S. W., Duerr, A. C., Heilig, C. M., Shah, K. V., Klein, R. S., Cu‐Uvin, S., Schuman, P. C., et al. (2006) · International Journal of Cancer · doi:10.1002/ijc.22015 · Cited by 91 · see citing works
Influence of age on histologic outcome of cervical intraepithelial neoplasia during observational management: results from large cohort, systematic review, meta-analysis
Bekos, C., Schwameis, R., Heinze, G., Gärner, M., Grimm, C., Joura, E. A., Horvat, R., Polterauer, S., & Polterauer, M. (2018) · Scientific Reports · doi:10.1038/s41598-018-24882-2 · Cited by 90 · see citing works
Interleukin-10 production by tumor infiltrating macrophages plays a role in Human Papillomavirus 16 tumor growth
Bolpetti, A. N., Silva, J. S., Villa, L. L., & Lepique, A. P. (2010) · BMC Immunology · doi:10.1186/1471-2172-11-27 · Cited by 90 · see citing works
Modifiable Risk Factors Associated with Clearance of Type-Specific Cervical Human Papillomavirus Infections in a Cohort of University Students
Richardson, H., Abrahamowicz, M., Tellier, P., Kelsall, G., du Berger, R., Ferenczy, A. S., Coutlée, F., & Franco, E. L. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0230 · Cited by 89 · see citing works
Heterogeneity in CIN3 diagnosis
Schiffman, M., & Rodríguez, A. C. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70110-4 · Cited by 88 · see citing works
Circular RNA circLMO1 Suppresses Cervical Cancer Growth and Metastasis by Triggering miR-4291/ACSL4-Mediated Ferroptosis
Ou, R., Lu, S., Wang, L., Wang, Y., Lv, M., Li, T., Xu, Y., Lu, J., & Ge, R. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.858598 · Cited by 87 · see citing works
Cell cycle and/or proliferation markers: what is the best method to discriminate cervical high-grade lesions?
Lorenzato, M., Caudroy, S., Bronner, C., Evrard, G., Simon, M., Durlach, A., Birembaut, P. L., & Clavel, C. (2005) · Human Pathology · doi:10.1016/j.humpath.2005.07.016 · Cited by 85 · see citing works
Interaction of immunological genes on chromosome 2q33 and IFNG in susceptibility to cervical cancer
Ivansson, E. L., Juko‐Pecirep, I., & Gyllensten, U. B. (2009) · Gynecologic Oncology · doi:10.1016/j.ygyno.2009.10.084 · Cited by 85 · see citing works
Can the prophylactic quadrivalent HPV vaccine be used as a therapeutic agent in women with CIN? A randomized trial
Karimi‐Zarchi, M., Allahqoli, L., Nehmati, A., Mehdizadehkashi, A., Zahir, S. H. T., & Alkatout, İ. (2020) · BMC Public Health · doi:10.1186/s12889-020-8371-z · Cited by 84 · see citing works
Human papillomavirus genotyping and p16INK4a expression in cervical intraepithelial neoplasia of adolescents
Hu, L., Guo, M., He, Z., Thornton, J. A., McDaniel, L. S., & Hughson, M. D. (2004) · Modern Pathology · doi:10.1038/modpathol.3800290 · Cited by 84 · see citing works
An analysis of temporal and generational trends in the incidence of anal and other HPV-related cancers in Southeast England
Robinson, D., Coupland, V. H., & Møller, H. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604871 · Cited by 84 · see citing works
Translational approaches to improving cervical screening
Baldwin, P., Laskey, R. A., & Coleman, N. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1010 · Cited by 84 · see citing works
Dynamics of HPV16 DNA load reflect the natural history of cervical HPV-associated lesions
Monnier‐Benoit, S., Dalstein, V., Riethmuller, D., Lalaoui, N., Mougin, C., & Prétet, J. (2005) · Journal of Clinical Virology · doi:10.1016/j.jcv.2005.09.001 · Cited by 82 · see citing works
Multiple-Type Human Papillomavirus Infection in Male Anogenital Sites: Prevalence and Associated Factors
Nielson, C. M., Harris, R. B., Flores, R., Abrahamsen, M. E., Papenfuss, M. R., Dunne, E. F., Markowitz, L. E., & Giuliano, A. R. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0447 · Cited by 81 · see citing works
Host Genetic Polymorphism Analysis in Cervical Cancer
Calhoun, E. S., McGovern, R. M., Janney, C. A., Cerhan, J. R., Iturria, S. J., Smith, D. I., Gostout, B. S., & Persing, D. H. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.8.1218 · Cited by 81 · see citing works
Adenocarcinoma of the Cervix: Should We Treat It Differently?
Williams, N. L., Werner, T. L., Jarboe, E. A., & Gaffney, D. K. (2015) · Current Oncology Reports · doi:10.1007/s11912-015-0440-6 · Cited by 76 · see citing works
Viral Load in the Natural History of Human Papillomavirus Type 16 Infection: A Nested Case–Control Study
Xi, L. F., Hughes, J. P., Castle, P. E., Edelstein, Z. R., Wang, C., Galloway, D. A., Koutsky, L. A., Kiviat, N. B., & SCHIFFMAN, M. H. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir049 · Cited by 76 · see citing works
HPV-16, HPV-58, and HPV-33 are the most carcinogenic HPV genotypes in Southwestern China and their viral loads are associated with severity of premalignant lesions in the cervix
Long, W., Yang, Z., Li, X., Chen, M., Liu, J., Zhang, Y., & Sun, X. (2018) · Virology Journal · doi:10.1186/s12985-018-1003-x · Cited by 76 · see citing works
Advances in primary and secondary interventions for cervical cancer: human papillomavirus prophylactic vaccines and testing
Wheeler, C. M. (2007) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0770 · Cited by 75 · see citing works
Influence of age and geographical origin in the prevalence of high risk human papillomavirus in migrant female sex workers in Spain
del Amo, J. (2005) · Sexually Transmitted Infections · doi:10.1136/sti.2003.008060 · Cited by 75 · see citing works
Determination of HPV type 16 and 18 viral load in cervical smears of women referred to colposcopy
Carcopino, X., Henry, M., Benmoura, D., Fallabregues, A. S., Richet, H., Boubli, L., & Tamalet, C. (2006) · Journal of Medical Virology · doi:10.1002/jmv.20673 · Cited by 74 · see citing works
Guidelines for Cervical Cancer Screening: History and Scientific Rationale
Waxman, A. G. (2005) · Clinical Obstetrics & Gynecology · doi:10.1097/01.grf.0000151590.08451.26 · Cited by 73 · see citing works
Persistence and clearance of human papillomavirus infection: a prospective cohort study
da Rosa, M. I., Fachel, J. M. G., Rosa, D. D., Medeiros, L. R., Igansi, C. N., & Bozzetti, M. C. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.06.033 · Cited by 70 · see citing works
Persistent HPV infection in postmenopausal age women
Smith, E., Johnson, S. R., Ritchie, J. M., Feddersen, D. A., Wang, D., Turek, L. P., & Haugen, T. H. (2004) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2004.07.013 · Cited by 72 · see citing works
Association between high-risk human papillomavirus DNA load and precursor lesions of cervical cancer in Mexican women
Hernández-Hernández, D. M., Ornelas-Bernal, L. A., Guido‐Jiménez, M., Apresa-García, T., Alvarado‐Cabrero, I., Salcedo–Vargas, M., Mohar, A., & García-Carrancá, A. M. (2003) · Gynecologic Oncology · doi:10.1016/s0090-8258(03)00320-2 · Cited by 72 · see citing works
Results of the First World Health Organization International Collaborative Study of Detection of Human Papillomavirus DNA
Quint, W. G. V., Pagliusi, S. R., Lelie, P. N., de Villiers, E., & Wheeler, C. M. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.44.2.571-579.2006 · Cited by 72 · see citing works
HPV16 Oncoproteins Induce MMPs/RECK-TIMP-2 Imbalance in Primary Keratinocytes: Possible Implications in Cervical Carcinogenesis
Cardeal, L. B. D. S., Boccardo, E., Termini, L., Rabachini, T., Andreoli, M. A., di Loreto, C., Longatto‐Filho, A., Villa, L. L., & Maria–Engler, S. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033585 · Cited by 71 · see citing works

Longitudinal relationship between human papillomavirus infection and the incidence and progression of precursor lesions of cervical neoplasia
Schlecht, N. F. (2002) · doi:10.82308/42716 · Cited by 1 · see citing works
Self-citation
Persistent HPV Infection and Cervical Intraepithelial Neoplasia
Rebar, R. W. (2002) · Journal watch · doi:10.1056/wh200202050000007
Persistence of an Incident Human Papillomavirus Infection and Timing of Cervical Lesions in Previously Unexposed Young Women
Trottier, H., Mahmud, S. M., Lindsay, L., Jenkins, D., Quint, W. G. V., Wieting, S. L., Schuind, A., Franco, E. L., & on behalf of the GSK HPV-001 Vaccine Study Group (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-1012 · Cited by 52 · see citing works
Relationship Between Human Papillomavirus Type 16 in the Cervix and Intraepithelial Neoplasia
ter Harmsel, B., SMEDTS, F., KUIJPERS, J., MUYDEN, R. V., OOSTERHUIS, W., & QUINT, W. (1999) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(98)00306-8 · Cited by 26 · see citing works
Persistent HPV Infection Is Associated with Cervical Intraepithelial Neoplasia
Rebar, R. W. (2002) · Journal watch · doi:10.1056/jw200201220000002

Authors: Schlecht, N. F.
Affiliations: McGill University (CA)
Corresponding author: Schlecht, Nicolas F.
ORCID: Schlecht, Nicolas F.
Venue: JAMA
Publisher: American Medical Association (AMA)
Published: 2001-12-26
Volume: 286
Issue: 24
Pages: 3106
ISSN: 0002-9955 (ISSN-L)
0098-7484
DOI: 10.1001/jama.286.24.3106
OpenAlex: W2161489192
Cited by: 590
References: 22
Citations by year: 2026: 6 · 2025: 5 · 2024: 15 · 2023: 12 · 2022: 10 · 2021: 10 · 2020: 15 · 2019: 16 · 2018: 12 · 2017: 13 · 2016: 21 · 2015: 28 · 2014: 28 · 2013: 18 · 2012: 27
FWCI: 20.86
Type: journal article
Language: en
Open access: closed
Locations: JAMA (publishedVersion)
PubMed (publishedVersion)
Funders: U.S. Public Health Service (MA13647)
National Cancer Institute (CA70269, R01CA070269)
Topics: Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Women's cancer prevention and management
Keywords: human papillomavirus, persistent HPV infection, cervical intraepithelial neoplasia, squamous intraepithelial lesions, HPV 16/18, cervical precancerous lesions, natural history of HPV infection, high-risk HPV genotypes, cervical cancer risk
MeSH terms: Adult, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, DNA, Viral, Female, Humans, Longitudinal Studies, Middle Aged, Risk Factors, Tumor Virus Infections, Vaginal Smears, Multivariate Analysis, Papillomaviridae, Papillomavirus Infections, Papanicolaou Test

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Persistent Human Papillomavirus Infection as a Predictor of Cervical Intraepithelial Neoplasia

Abstract

Integrity signals

Claims the paper makes

Claims other papers make about this one

Cites

Cited by

Related

Record

About these checks